CXCL5 and cerebral small vessel disease: With a working model suggesting that DIO drives white matter endothelial CXCL5 expression through IL-17B/IL-17Rb signaling, we sought to establish the relevance of this signaling cascade to human cerebral small vessel disease and vascular cognitive impairment.